Weekly CEO News from Richard Ingram
September 8, 2015

The Chart of the Day belongs to La Jolla Pharmaceuticals (LJPC). I found the biological pharmaceutical stock by using Barchart to sort the Russell 3000 Index stocks first for the highest Weighted Alpha then again for Barchart technical buy signals

Read more

Based on the headline from the latest Jobs Friday report you wouldn’t know that we are still mired in an economic emergency–one apparently so extreme that it might entail moving to the 81st straight month of zero interest rates at next week’s FOMC meeting. After all, the unemployment rate

Read more

Asia saw a mixed session where most markets were lower but talk of intervention in China saw a very healthy bounce in the last few minutes of trading (Nikkei -2.5% Shanghai and HSI both up around 3%). Europe started on a positive

Read more

“The woods decay, the woods decay and fall, The vapours weep their burthen to the ground, Man comes and tills the field and lies beneath, And after many a summer dies the swan.” Tennyson, Tithonus Among the usual suspects worth watching,

Read more

Not that it really matters, but this happens to be the 16,000th post (you read that right – sixteen thousandth) on this blog platform. That doesn’t mean it is the 16,000th one on Slope, because this platform only holds the posts going

Read more

If it was the Fed’s intention to make the upcoming rate hike seem like a welcome event, one that presaged a new Golden Age in the US (and global) economy because, lo and behold, the wise Fed would never hike unless the

Read more

Shares of Tetraphase Pharmaceuticals (TTPH) are down 80% after the company announced that the primary endpoint for its phase 3 IGNITE2 clinical trial of intravenous (transitioning to oral) eravacycline failed to reach statistical significance. The trial  enrolled up to 908

Read more

Coming off of a volatile month of August, where the S&P 500 index fell by over 6% on a total return basis, many stock market investors are looking for indications of what lies ahead for the final four months of

Read more

I know what you’re thinking. This market is bouncing all over the place and there is very little leadership. At a time like this where China is collapsing, the domestic market is experiencing tremors and the Fed’s about to raise

Read more

The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. August was exciting as ever as my year over year

Read more